The pharmacy profession should be actively involved in the development of guidelines and protocols for various disease states. Good research to demonstrate that interventions by pharmacists result in good clinical outcomes and money saved is scarce. Pharmacy is in the early throes of change as a result of growth within the profession. In the future, pharmacists will be more involved in clinical evaluations and less with drug dispensing duties because of advances in automation. The new Medicare Part D program is a real opportunity for pharmacists to be actively engaged in patient education and treatment monitoring.
*Address reprint requests to H. William Kelly, Pharm.D., BCPS, Department of Pediatrics, ACC Building 3rd Floor, University of New Mexico Health Sciences Center, 2211 Lomas Boulevard NE, Albuquerque, NM 87131-5311
You have no access to this article
